Randomized Controlled Study Comparing the Efficacy and Tolerance of Bepotastine, a New 2nd Generation Antihistamine, to Fexofenadine, in Symptomatic Relief of Patients with Pruritic Cutaneous Disorders
Autor: | Amit Bhargava, Harsha Mahajan, Sushil Chaudhari, Varsha Narayanan |
---|---|
Rok vydání: | 2018 |
Předmět: |
medicine.medical_specialty
Fexofenadine business.industry medicine.medical_treatment Cutaneous Disorders Dermatology Symptomatic relief law.invention 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine 030228 respiratory system Randomized controlled trial law Medicine Bepotastine Antihistamine business medicine.drug |
Zdroj: | Journal of Clinical & Experimental Dermatology Research. |
ISSN: | 2155-9554 |
DOI: | 10.4172/2155-9554.1000466 |
Databáze: | OpenAIRE |
Externí odkaz: |